Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
NCT00377949 is an observational study sponsored by Georgetown University. As of 21 Nov 2026, it is completed. It studies Pulmonary Arterial Hypertension, Pulmonary Hypertension and 2 more conditions. The registry lists an enrollment of 602 participants at 25 sites in 1 country. The registry lists a start date of 28 Feb 2005 and a primary completion date of 31 Jan 2016.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT00377949 |
| Status | Completed |
| Study type | Observational study |
| Lead sponsor | Georgetown University |
| Enrollment | 602 |
| Registered sites | 25 |
| Countries | 1 |
| Conditions | Pulmonary Arterial Hypertension, Pulmonary Hypertension, Scleroderma and Systemic Sclerosis |
| Start | 28 Feb 2005 |
| Primary completion | 31 Jan 2016 |
| Last update posted | 3 May 2016 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Virginia D. Steen, MD
Georgetown University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucla Medical Center
Los Angeles
- Stanford University
Stanford
- National Jewish Medical and Research Center
Denver
- Georgetown University Medical Center
Washington D.C.
- Northwestern University
Chicago
- University of Chicago
Chicago
- Louisiana State University Health Science Center
New Orleans
- John Hopkins University Medical Center
Baltimore
- Boston University Medical School
Boston
- Tufts Medical Center
Boston
- University of Massachussetts Memorial Medical Center
Worcester
- University of Michigan-Scleroderma Program
Ann Arbor
- Hennepin County Medical Center
Minneapolis
- University of Minnesota
Minneapolis
- University of Medicine and Dentistry of New Jersey
New Brunswick
- Center for Rheumatology
Albany
- North Shore Long Island Jewish Medical Center
New Hyde Park
- Cornell University
New York
- Hospital for Special Surgery
New York
- University of Pennsylvania
Philadelphia
- University of Pittsburgh
Pittsburgh
- Medical University of South Carolina
Charleston
- the University of Texas Health Science Center
Houston
- University of Utah
Salt Lake City
- the Medical College of Wisconsin
Milwaukee
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT00377949
Each answer restates registry values shown on this page.
What is NCT00377949?
NCT00377949 is an observational study sponsored by Georgetown University. It studies Pulmonary Arterial Hypertension, Pulmonary Hypertension and 2 more conditions.
Who leads NCT00377949?
The registry names Virginia D. Steen, MD (principal investigator, Georgetown University) as the overall official.
Where does NCT00377949 run?
The registry lists 25 sites in 1 country. Every site with a stated country is in one country: United States.
When did NCT00377949 end?
The registry lists a primary completion date of 31 Jan 2016. The sponsor last updated the record on 3 May 2016.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.